O.N. CHEVPLYANSKAYA, M.V. DUDAREV

Izhevsk State Medical Academy, 281 Kommunarov St., Izhevsk, Russian Federation, 426034

Chevplyanskaya O. N. — postgraduate student of the Polyclinic Therapy Department with courses of Clinical Pharmacology and Preventive Medicine of Advanced Training Faculty and professional retraining, tel. +7-912-748-38-79, e-mail: chevoks@yandex.ru

Dudarev M. V. — D. Med. Sc., Associate Professor, Head of the Polyclinic Therapy Department with courses of Clinical Pharmacology and Preventive Medicine of Advanced Training Faculty and professional retraining, tel. (3412) 20-37-66, e-mail: flatly@yandex.ru

The study examines the estimation of the prevalence of factors of cardiovascular risk and characteristics of early preclinical signs of heart disease in young patients with high normal blood pressure. The survey included 38 young men aged 18-32 years. In every patient there were estimated anthropometric parameters, laboratory indicators, were made echocardiography with assessment of systolic and diastolic function, perforating arteries. For the analysis of structural changes in left ventricular myocardium was used the speckle tracking echocardiography (STE) with an assessment of the global longitudinal strain. The results showed a high prevalence of traditional risk factors in young men with high normal blood pressure. It was found that echocardiography with the use of speckle tracking is a highly informative assessment method of the left ventricular myocardium in the early stages of hypertension. Reduced blood flow in perforating arteries in diastole is an initial sign of vascular changes in patients with prehypertension.

Key words: high normal blood pressure, heart damage, speckle tracking echocardiography.

REFERENCES

1. Filippov E.V., Yakushin S.S. The prevalence of hypertension and especially the management of patients with hypertension and the risk of various cardiovascular complications. Meditsinskiy sovet, 2013, no. 9, pp. 65-69 (in Russ.).
2. Fomin I.V., Badin Yu.V., Polyakov D.S. et al. Prehypertension:. How common is this condition the cardiovascular system of the citizens of the European part of Russia (research data AGE-AG, 2012-2017). Klinicheskaya meditsina, 2013, vol. 2, no. 5, pp. 38-46 (in Russ.).
3. Antonakoudis G., Poulimenos L., Kifnidis K. et al. Blood pressure control and cardiovascular risk reduction. Hippokratia, 2007, vol. 3, no. 11, pp. 114-119.
4. Mancia G., Fagard R., Narkiewicz K. et al. 2013 ESH/ESC Guidelines for themanagement of arterial hypertension. The Task Force for the management ofarterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), available at: www.jhypertension.com
5. Sitia S., Tomasoni L., Turiel M. Speckle tracking echocardiography: A new approach to myocardial function. World J Cardiol, 2010, vol. 2, pp. 1-5.
6. Alekhin M.N. Ul’trazvukovye metody otsenki deformatsii miokarda i ikh klinicheskoe znachenie [Ultrasonic methods of assessment of myocardial deformation and their clinical significance]. Moscow: Vidar-M, 2012. P. 88.
7. Dzyak G.V., Kolesnik M.Yu. Features of deformation and rotation infarction in men with arterial giperteniey and varying degrees of left ventricular hypertrophy. Kardiologiya, 2014, no. 6, pp. 9-14 (in Russ.).
8. Fegenbaum H., Mastouri R., Sawada S. A practical approach to using strain echocardiography to evaluate the left ventricle. Circ J, 2012, vol. 76, pp. 1550-1555.
9. Stryuk R.I., Burlakova B.N., Berns S.A., Potievskiy B.G. Risk factors for hypertension and metabolic disorders in otherwise healthy males. Kardiologiya, 2014, no. 1, pp. 13-17 (in Russ.).
10. Chicherina E.N., Padyganova A.V. Factors for the development and progression of complications in women cardiorenal. Terapevticheskiy arkhiv, 2013, no. 6, pp. 85-89 (in Russ.).
11. Verdecchia P., Schillaci G., Reboldi G. et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the Piuma Study. Hypertension, 2000, vol. 36, pp. 1072-1078.
12. Mattace-Raso F., Hofman A., Verwoert G.C. et al. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: “establishing normal and reference values. The Reference Values for Arterial Stiffness”. Eur. Hart. J, 2010, vol. 31, pp. 2338-2350.
13. Dmitriev V.A., Oshchepkova E.V., Titov V.N. et al. Is Us uric acid level has a pre-clinical target organ damage in hypertensive patients of medium and high risk? Terapevticheskiy arkhiv, 2013, no. 9, pp. 52-57 (in Russ.).
14. Culleton B.F., Larson M.G., Kannel W.B., Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med, 1999, vol. 131, pp. 7-13.
15. Moiseev B.C., Mukhin N.A., Smirnov A.V. et al. National guidelines. Cardiovascular risk and chronic kidney disease: a strategy cardio nefroprotektsii. Rossiyskiy kardiologicheskiy zhurnal, 2014, no. 8, pp. 7-37 (in Russ.).
16. Beloglazova I.P., Mogutova P.A, Poteshkina N.G. Patogeneticheskie osnovy kardiorenal’nogo sindroma. Terapevticheskiy arkhiv, 2012, no. 9, pp. 97-103 (in Russ.).
17. Julien J., Tronche C., Souchet T. Left ventricle hypertrophy in hypertensive patients. Arch Mal Coeur Vaiss, 2004, vol. 97, pp. 221-227.
18. Pavlyukova E.N. Karpov R.S. The deformation, rotation and the rotation axis of the left ventricle in patients with coronary heart disease with severe left ventricular dysfunction. Terapevticheskiy arkhiv, 2012, no. 9, pp. 11-16 (in Russ.).
19. Kurlyanskaya E.K., Ostrovskiy Yu.P., Trofimova T.A. et al. The possibilities of non-invasive assessment of myocardial deformation properties. Evraziyskiy kardiologicheskiy zhurnal, 2011, no. 6, pp. 61-65 (in Russ.).
20. Alekhin M.N. Ultrasound evaluation of myocardial deformation techniques and their clinical significance. Two-dimensional tracking spots grayscale ultrasound images of the myocardium in the evaluation of deformation and twisting (Lecture 2). Ul’trazvukovaya i funktsional’naya diagnostika, 2011, no. 3, pp. 107-120 (in Russ.).